Participants in trials undergo regular monitoring of weight, blood glucose, HbA1c, lipid profile, liver and renal function, and cardiovascular parameters
Conclusion The potential value of oral L-carnitine in reversing carnitine deficiency and preventing adverse effects due to VPA-induced dysfunction of -oxidation is suggested by several studies and isolated observations
When studied together as a blend, it is theorized that their complementary mechanisms may enhance healing processes beyond what either peptide demonstrates alone
Contact of nutrients with L-cells in the distal gut likely explains the prolonged duration of elevated GLP-1 during meals, and it might also be responsible for the typically observed increased levels of GLP-1 following gastric bypass and, albeit less so, after sleeve gastrectomy surgery [[211], [212], [213], [214], [215], [216]], because surgical repositioning of the distal gut more rapidly exposes the distal L-cells to incoming nutrients [144]
Ongoing and future clinical trials are expected to further define the cardiovascular role of GLP-1 RAs, expand their therapeutic indications, and solidify their place in the evolving landscape of cardiovascular care